Moreover, this work provides evidence that combined treatment with a PI3K inhibitor and sunitinib suppresses hypervascularization without enhancing vegfaa expression, suggesting a new approach for therapeutic intervention in VEGFR-signaling-dependent tumors such as hemangiosarcomas. The gene discussed is KDR; the disease is angiosarcoma.